UK Accelerated Access Review Can Create A Post-Brexit 'Medtech Powerhouse'

Medical technology stakeholders in the UK will be poring over the detail of the much-anticipated Accelerated Access Review (AAR), the final report of which was released Oct. 24. The initial response from the industry has been positive.

Access

More from Policy & Regulation

More from Medtech Insight